Search Results 381-390 of 9166 for Mediate

  1. Preclinical study suggests strategy for re-myelination - Mayo Clinic

    CD38 expression increased in mouse spinal cords following chronic high fat consumption, after focal toxin-mediated de-myelinating injury and in reactive ...

  2. Publications - George W. Marek, III, M.D., Ph.D. - Mayo Clinic

    Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity. Am J Respir Cell Mol Biol. 2017 Aug; 57 (2):238-247. View ...

  3. CAR-T Cell Therapy Clinical Trials - Mayo Clinic Research

    ... mediates durable antitumor responses after infusion. ... Less differentiated T cells have shown an increased ability to proliferate, persist, and mediate ...

  4. Publications - Mary E. Fidler, M.D. - Mayo Clinic

    Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant. 2004 Jan; 4 (1):101 ...

  5. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

    ... mediated B-cell cytotoxicity. Mössner E. Ekkehard; Brünker P. Peter; Moser S. Samuel; Püntener U. Ursula; Schmidt C. Carla; Herter S. Sylvia; Grau R. Roger ...

  6. Vasovagal syncope - Symptoms and causes - Mayo Clinic

    Vasovagal syncope also is called neurocardiogenic syncope. The vasovagal syncope trigger causes your heart rate and blood pressure to drop suddenly. That leads ...

  7. Integrative Biology of Advanced Liver Disease: Vijay Shah

    This is informed by spatially resolved gene regulatory changes and potential alterations in condensate-mediated stress signaling within alcohol-affected hepatic ...

  8. Na Zhao - Mayo Clinic Faculty Profiles

    Zhao aims to collectively address the dynamic effects of TREM2 -mediated molecular pathways in AD and related dementias to both explore disease mechanisms and ...

  9. A Study of the Benefits and Risks of Nulojix® (Belatacept)-Based Maintenance Immune Rejection Suppression for Kidney Transplant Recipients - Mayo Clinic

    History of antibody mediated rejection; Positive T-cell lymphocytotoxic cross match; Proteinuria >1 g/day or >0.5 g/day if diabetic. Participating Mayo Clinic ...

  10. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    History of immune-mediated pneumonitis. Current or prior use of immunosuppressive medication within 14 days prior to the first dose of study treatment ...